CNS pipeline · person
Steven Paul, MD
Founder and Chair of the Board of Seaport Therapeutics; physician-scientist with 40+ years in neuroscience and CNS drug discovery. Former President and CEO of Karuna Therapeutics, co-founder of Sage Therapeutics and Voyager Therapeutics, and previously spent 17 years at Eli Lilly leading CNS drug development (including Zyprexa and Cymbalta).
- 1 company
Courtesy Seaport Therapeutics
Current roles
- Seaport Therapeutics, Inc.Founder and Board Chair · Founder
Appears with
People sharing a company with Steven.
- Antony Loebel · Seaport Therapeutics, Inc.
- Bob Hombach · Seaport Therapeutics, Inc.
- Daphne Zohar · Seaport Therapeutics, Inc.
- David Wheadon · Seaport Therapeutics, Inc.
- Denice Torres · Seaport Therapeutics, Inc.
- Eric Green · Seaport Therapeutics, Inc.
- Jason Pitts · Seaport Therapeutics, Inc.
- Jim Healy · Seaport Therapeutics, Inc.
- Lana Gladstein · Seaport Therapeutics, Inc.
- Lauren White · Seaport Therapeutics, Inc.
- Michael Chen · Seaport Therapeutics, Inc.
- Sandi Peterson · Seaport Therapeutics, Inc.
- Sharon Mates · Seaport Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.